Abstract
98 Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L-FMAU, DAPD, penciclovir and lobucavir : C. Ying, 1 E. De Clercq, 1 W. Nicholson, 2 P. Furman 2 and J. Neyts 1,∗ 1Rega Institute for Medical Research, K.U.Leuven, B-3000 Leuven, Belgium; 2Triangle Pharmaceuticals, Durham, North Carolina 27707, USA
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
